The suspense is killing me.Tony "The Bull" Severino, CMT (@TonyTheBullCMT):Litecoin LTCUSDMassive volume at triangle apex. Momentum about to diverge up at the zero line on the LMACD https://t.co/44M5VpiSAJ ...

Market Impact of Tariffs - Markets do not fully believe tariffs will be implemented on August 1st, otherwise markets would be significantly lower [1] - Pushing the tariff deadline suggests room for negotiation, but the 10% baseline tariff remains a floor [2] - The threat of tariffs has led some investors to seek opportunities in Europe [3] - Tariffs have weakened the dollar, benefiting international stocks for US investors [5] - US tariffs may catalyze fiscal impulse in Europe, China, and Japan, potentially boosting international diversification in the long term [6] Market Momentum and Strategy - Momentum begets momentum; new all-time highs can lead to further gains [7] - Investors should lean into the market momentum rather than taking profits despite trade anxieties and stretched valuations [8] - The spread thrust off the lows is a bullish indicator [8] Financial Sector Preference - The speaker favors big banks (KBE) over regional banks (KRE) due to regulatory tailwinds and M&A/IPO activity [9][10] - Big banks are expected to overcome sentiment hurdles during the upcoming earnings season [11] - Banks are preferred over insurance due to their cyclical nature and potential for higher profits and growth [12][13] Cyclical Sectors and Investment Strategy - The speaker favors cyclical sectors but prefers high-quality, large-cap companies [14] - While industrials and small caps are cyclical, there's hesitation on small caps due to rate headwinds and idiosyncratic challenges [14]

Group 1 - Navitas (NASDAQ: NVTS) experienced a significant stock price increase from $2 to $6.50, largely driven by a venture prospect with Nvidia (NVDA) [1] - The author emphasizes a focus on momentum in the technology market, drawing from over two decades of experience navigating various market conditions, including the dot com bubble and the recent AI boom [1] Group 2 - No specific financial data or performance metrics were provided in the articles [2][3]

Group 1 - Leveraged ETFs are generally viewed as poor investment vehicles due to high expenses and volatility, often launched after investment narratives have already occurred [1] - The investment strategy discussed involves a balanced portfolio of low-cost funds and single stocks, with a focus on long-term holding and understanding market dynamics beyond just numerical analysis [2] - The analyst expresses a bullish outlook on specific stocks including AMD, PLTR, TSLA, and Bitcoin, indicating a positive sentiment towards these investments [2] Group 2 - Leveraged products like SOXL are associated with high risks, including potential for amplified losses and high expense ratios, suggesting caution for investors [4] - The article emphasizes the importance of conducting personal research and aligning investments with individual financial objectives and risk tolerance [4]

With the NASDAQ hitting a record high in Nvidia at $4 trillion, let's bring in Steve Sausnik, Interactive Brokers Chief Strategist. Uh Steve, what do you make of this. Especially against the backdrop of some of the uh the recent moves and momentum that we've seen.Well, Leslie, it's to me I could characterize this market as a combination of FOMO and FOMO. It's it's momentum. There's also a fear of missing out.I you know, I think the Nvidia number is a nice milestone. You know, once it gets sort of in the pub ...

Market Momentum and Investor Sentiment - The market is currently driven by "Momo" (momentum), where trends are strong and investors believe "the trend is your friend" [2][3] - "FOMO" (fear of missing out) is prevalent, with investors joining the rally to avoid being left behind, potentially disregarding fundamentals [4] - The sustainability of the rally is questionable, as external forces could disrupt the current momentum [4][5] Potential Risks and External Factors - The expiration of tariff moratoria is mentioned, but considered a non-factor as they are likely to be rolled ahead [6] - The bond market's reaction to budget deficit concerns and "voterama" is a potential risk [7] - Earnings season is approaching, and while trend following is present, earnings ultimately matter [7] Earnings Season Outlook - There are conflicting signals regarding the upcoming earnings season, with some expecting a bumpy season based on corporate tax revenue, while others anticipate continued market momentum driven by earnings [7] - The extent to which expectations are factored into earnings results is a key uncertainty [8] - A weaker dollar could provide a tailwind for multinational earnings, but also indicates potential capital outflow from the US [8] - High expectations for earnings could lead to disappointment if results fall short, as seen with Micron [9]

Core Viewpoint - Archer Aviation Inc. (NYSE: ACHR) has been under observation for its quarterly earnings, with expectations for revenue generation remaining unmet over time [1] Company Analysis - The company has not posted any revenue in its quarterly earnings, which raises concerns about its financial performance and growth potential [1] Industry Context - The broader context includes a focus on momentum in the technology sector, particularly in relation to risk mitigation strategies observed during significant market events such as the dot-com bubble and the credit crisis of 2008 [1]

Reminder: #Altseason often starts in silence.The real moves?They happen between midnight and sunrise.Track volume. Track momentum. 📊 ...

Core Insights - Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is currently viewed as a promising investment opportunity based on recent observations [1] Company Overview - The company has been under close observation for a significant period, indicating a potential shift in market dynamics that could favor its stock performance [1] Market Context - The investment landscape has been influenced by various historical events, including the dot com bubble, the credit default crisis of 2008, and the recent AI boom, suggesting that the company operates in a volatile yet potentially lucrative environment [1]

I've been keeping a close eye on Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT ) for quite some time. I like what they do; their main focus is on gastrointestinal disorders, and they have a pretty promising drugI’m a retired Wall Street PM specializing in TMT; since kickstarting my career, I’ve spent over two decades in the market navigating the technology landscape, focusing on risk mitigation through the dot com bubble, credit default of ‘08, and, more recently, with the AI boom. In one word, what I’d like ...